Treatment with a novel one-time gene therapy improved motor function and extended survival in a mouse model of amyotrophic…
Articles by Marisa Horak, MS
A panel of 19 blood proteins may help estimate when symptoms of amyotrophic lateral sclerosis (ALS) will emerge in people…
For people serving in the U.S. armed forces, the risk of developing amyotrophic lateral sclerosis (ALS) varies by military…
Mutations in the NEK1 gene — a major genetic cause of amyotrophic lateral sclerosis (ALS) — can disrupt the molecular…
Abnormal levels of certain fatty molecules in the body — which are broken down by metabolism to support daily functions…
RAG-17, an experimental RNA-targeting therapy designed to treat amyotrophic lateral sclerosis (ALS) caused by mutations in the SOD1 gene, was…
A feature documentary airing on PBS delves into a man’s final years living with amyotrophic lateral sclerosis (ALS), offering…
Targeting a specific part of the TDP-43 protein can prevent toxic protein clumping that drives amyotrophic lateral sclerosis (ALS)…
A new wearable soft-glove device has successfully restored hand function in a man with amyotrophic lateral sclerosis (ALS), allowing…
Neuralink, a company developing brain-computer interface (BCI) devices aimed at restoring independence to people with paralysis caused by conditions…